Event
17th International Congress on Myeloproliferative Neoplasms
presented by 17th International Congress on Myeloproliferative Neoplasms
3 others would like to attend.
Register Now
New York Marriott at the Brooklyn Bridge 333 Adams Street Brooklyn, NY 11201
Event info
Overview
We are delighted to invite you to attend the 17th International Congress on Myeloproliferative Neoplasms convening on November 6-7, 2025 at the New York Marriott-Brooklyn Bridge in Brooklyn, New York. This event, founded in 2001, and now held annually, serves as a cornerstone for advancing education about the myeloproliferative neoplasms (MPN).
The two-day program features world-renowned faculty and offers CME credits for physicians and CE credits for nurse practitioners, physician assistants, and nurses. With an emphasis on robust faculty interaction and active audience engagement, the MPN Congress features an interactive format with a Q&A session following each speaker’s presentation. In addition, based on positive feedback from the last Congress, we will continue both the debate session and the nurse-led session.
Participants can also enjoy numerous networking opportunities and one-on-one discussions with the faculty and other attendees, promoting collaboration and knowledge-sharing among professionals in the MPN field.
Learning Objectives
Upon completion of this educational activity, learners should be better able to:
1. Explain the pathogenesis, clinical manifestations, and diagnostic approaches for myeloproliferative neoplasms (MPNs).
2. Describe current and emerging therapeutic strategies for MPNs.
3. Discuss the management of disease-related complications in MPN patients.
4. Recognize the importance of multidisciplinary approach in the management of MPNs.
Target Audience
This educational activity is intended for hematologists, medical oncologists, translational scientists, and other healthcare professionals (physicians, clinicians, physicians-in-training, oncology nurse practitioners, physician assistants, nurses, etc.) involved and/or interested in the therapeutic management of patients with myeloproliferative neoplasms and related disorders.
Accreditation
For more information, please visit the official event page.
3 others would like to attend.
Register Now